Interestingly a recent report showed that, although 5-azacytidine (5-AZA) reduced DNMT1 expression levels in PC3 and DU145 cells, this result was associated with EMT and cancer stem cell (CSC) phenotypes, events likely to be counterproductive when treating PCa [65]. This evidence concerns the gene DNMT1 and cancer.